– Investor Day
Bayer’s Kidney Disease Drug Disappoints On Cutting Cardiovascular Death
Bayer AG (OTC:BAYRY) reported disappointing results from its approved med Kerendia (finerenone) didn’t reach significance on all-cause mortality in a pooled…